Rationale: Perianal fistula is a burdening disease with an annual prevalence of 2/100.000 in the Dutch population. More than 90% of crypto-glandular fistulas originate from anorectal abscess. Despite adequate drainage of anorectal abscess up to 83% recurs or results in an anal fistula, the majority developing within 12 months. Up till now it is not common practice to routinely administer prophylactic antibiotics to prevent anal fistula development.\\ Objective: The objective of this trial is to establish if adding antibiotic treatment to surgical drainage of perianal abscess results in less perianal fistulas. Study design: The study concerns a double-blind, placebo-controlled, randomized, multicenter trial with treatment of perianal abscess by surgical drainage alone or combined with antibiotic treatment. Patients will be accrued by all participating clinics. The design involves allocation of all appropriate consecutive patients with a primary occurrence of perianal abscess to surgical drainage followed by either antibiotics or placebo. Data will be analyzed on 'intention to treat' basis in case patients are not subjected to the randomized treatment modality. Study population: Men and women of 18 years and older who present for the first time with a perianal abscess. Intervention (if applicable): The antibiotic group receives 7 days of oral metronidazole (500 mg every eight hours) and ciprofloxacin (500 mg every twelve hours) in addition to surgical drainage. The other group receives surgical drainage and postoperatively identical placebo tablets. Main study parameters/endpoints: Primary outcome measure is development of a perianal fistula. Secondary outcome measures are quality of life at 12 months measured with the EQ-5D-5L with Dutch rating. Further: in-hospital direct and indirect costs and out-of hospital postoperative costs, need of repeated drainage, patient related outcome (PRO) and clinical outcome measures. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: For this study, patients are asked to take part in a study comparing the addition of antibiotic treatment to surgical drainage of perianal abscess. Patients will not be burdened by extra hospital visits. At baseline participants will complete PRO questionnaires. Also at 1 week and 3, 6 and 12 months participants will fulfill the PRO questionnaires. These will be send to them by email and will take approximately 10 minutes each time.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
298
One tablet of 500mg Ciprifloxacine, twice a day
One tablet of 500mg Metronidazole, three times a day
Placebo tablets
Amphia hospital
Breda, North Brabant, Netherlands
RECRUITINGElisabeth-TweeSteden ziekenhuis
Tilburg, North Brabant, Netherlands
RECRUITINGOLVG
Amsterdam, North Holland, Netherlands
RECRUITINGRode Kruis ziekenhuis
Beverwijk, North Holland, Netherlands
RECRUITINGDijklander hospital
Hoorn, North Holland, Netherlands
RECRUITINGAlbert Schweitzer ziekenhuis
Dordrecht, South Holland, Netherlands
RECRUITINGProctos kliniek
Bilthoven, Utrecht, Netherlands
RECRUITINGFlevoziekenhuis
Almere Stad, Netherlands
RECRUITINGUniversity Medical Center location AMC
Amsterdam, Netherlands
RECRUITINGIJsselland ziekenhuis
Capelle aan den IJssel, Netherlands
RECRUITING...and 1 more locations
Perianal fistula at 1 year follow up
A perianal fistula is diagnosed based on findings from physical examination or by a telephone call after 12 months were the doctor asks for symptoms as serosanguinous discharge and pain. An external opening with or without serosanguilent discharge is considered a fistula. In case of doubt an endoanal ultrasonography or MRI is performed. So: yes/no fistula (dichotomous parameter)
Time frame: 1 year
Quality of life at 12 months measured with the EQ-5D-5L with Dutch rating.
The EQ-5D-5L is a generic Health Related Quality of Life (HRQoL) measure, which is broadly used in economic evaluation. The instrument examines a patient's HRQoL on the day of the interview. It consists of the EQ-5D-5L descriptive system and the EQ-Visual Analogue Scale. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses to the 5 items result in a patient's health state that can be transformed into an index score representing health-related quality of life, ranging between 0 (death) and 1 (full health). These index scores are combined with length of life to calculate the QALY. The EQ-VAS records the patient's self-rated health with endpoints labelled 'the best health you can imagine' at the top and 'the worst health you can imagine' at the bottom.
Time frame: 1 year
In-hospital direct and indirect costs and out-of hospital posteroperative costs
In-hospital direct and indirect costs (measured with iPCQ and iMCQ) and out-of hospital postoperative costs.
Time frame: 1 year
Need of repeated drainage
Time frame: 1 year
PROMs
Patient related outcome (PRO) are complaint reduction assessed by a proctology specific validated patient-related outcome measure, the proctoPROM(14). This was recently developed and validated at Proctos Clinic. At baseline participants will complete PRO questionnaires. Also at 1 week and 3, 6 and 12 months participants will fulfill the PRO questionnaires. These will be send to them by email with access to a web tool (Castor). If the patient does not have an email account, the questionnaires will be send the patients' home address, accompanied by a return envelope provided with postage stamps and the address of the hospital.
Time frame: 1 year
Day of discharge from hospital
Day of discharge from hospital;
Time frame: 1 year
Postoperative complications
Complications (postoperative bleeding, urinary retention requiring catheterisation, emergency reoperation, anal stenosis and fecal incontinence) including death and cause of death within 30 days will be reported using the Clavien-Dindo classification of surgical complications(15).
Time frame: 1 year
Recurrent abscess
(Recurrent) abscess within one year. Yes/no (dichotomous)
Time frame: 1 year
Duration of absence from work
Duration of absence from work. Amound of days is recorded (continuous scale)
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.